Zivko Mukaetov Net Worth: Reliable Estimate and How to Verify

Živko Mukaetov is the CEO and Chairman of the Board of Directors of Alkaloid AD Skopje, one of North Macedonia's largest pharmaceutical and chemical companies. As of late 2024, the most credible regional estimate places his net worth at approximately €784 million, ranking him as the wealthiest individual in North Macedonia and 32nd on the list of the 100 richest people from the former Yugoslavia. That figure is an estimate, not a disclosed personal balance sheet, and the realistic range sits somewhere between €600 million and €900 million depending on how Alkaloid's privately held assets and equity are valued at any given time.

Who Zivko Mukaetov is (and why net worth searches vary)

There is really only one prominent public figure carrying this name: Živko Mukaetov, born May 3, 1974, in North Macedonia. He holds an MSc in Marketing Management from London and has spent essentially his entire career at Alkaloid, rising from management roles documented in the company's annual reports as far back as 2003 to his current dual role as General Director and President of the Board of Directors. He has also served as Honorary Consul General for Denmark in Skopje, adding a diplomatic credential to his public profile.

Net worth search results vary for a few practical reasons. First, Alkaloid is not a publicly traded company in the conventional sense that requires real-time market capitalization disclosures, so valuations depend on periodic financial reports and analyst estimates rather than a live share price. Second, different regional outlets publish lists at different times, using different valuation methodologies. Third, the name is transliterated several ways in Latin script (Zivko, Živko, Zivco) and appears in Macedonian, Serbian, Croatian, and Bosnian media, which fragments search results. All of those searches are pointing to the same person.

Current net worth estimate and realistic range

The figure most consistently cited in late 2024 regional coverage is €784 million. This number appeared simultaneously in reporting by 4news.mk (December 29, 2024), BALK Magazine (December 28, 2024), and Novi list, all of which attributed the figure to an Oslobođenje-sourced list of the 100 richest people from the former Yugoslav space. Mukaetov is listed at 32nd place on that ranking and identified specifically as Alkaloid's owner. That convergence across multiple independent outlets gives the figure more credibility than a single-source estimate.

The range acknowledges that private company valuations can shift meaningfully based on revenue cycles, pharmaceutical market conditions, and currency fluctuations between the Macedonian denar, euro, and other regional currencies. Until Alkaloid's equity is independently audited or sold in a public transaction, the exact figure remains an informed approximation.

How reliable is this estimate?

What the sources actually say

The €784 million figure traces back to a regional wealth ranking compiled by Oslobođenje, a well-established Bosnian news outlet. Regional rich lists like this typically derive their estimates from a combination of company revenue data, ownership stakes, real estate records, and comparable transactions in the pharmaceutical sector. They are not equivalent to a certified audit, but they are not pure guesswork either. The fact that the number was echoed by editorially independent outlets in North Macedonia, Croatia, and the broader Balkans media space within the same 48-hour window suggests it originates from a single, reasonably researched primary source rather than circular repetition.

What the methodology likely looks like

For private-company owners like Mukaetov, net worth estimates are typically built by taking the company's annual revenue or EBITDA and applying an industry valuation multiple, then attributing the result proportionally to the controlling owner. Alkaloid employs more than 2,000 people, including approximately 600 outside North Macedonia, and operates across pharmaceutical, cosmetic, and chemical product lines with regional and export reach. That scale places Alkaloid firmly in mid-large regional enterprise territory, where comparable pharmaceutical companies in Central and Eastern Europe command valuations in the hundreds of millions to low billions of euros. An estimate of €784 million for the controlling shareholder is consistent with that context.

Where uncertainty creeps in

• Alkaloid's exact ownership structure and Mukaetov's precise equity percentage are not publicly disclosed in detail, so the estimate assumes majority or controlling ownership.
• Company valuation multiples fluctuate with market conditions, interest rates, and sector sentiment.
• Personal liabilities, debt, and private investment losses are not captured in these estimates.
• Currency conversion between Macedonian denar and euro introduces additional variability.
• No personal financial disclosure requirement exists for private-company executives in North Macedonia equivalent to, for example, U.S. SEC filings.

Where the wealth likely comes from

The overwhelming driver of Mukaetov's estimated wealth is his ownership stake and leadership role at Alkaloid. He has been part of Alkaloid's management since at least 2003, became a board member in 2004, and was appointed President of the Board of Directors in 2007, a role he has held for nearly two decades. That length of tenure at a growing pharmaceutical company means his wealth has compounded alongside the company's expansion rather than arriving in a single liquidity event.

Executive compensation at companies of Alkaloid's scale and profitability in the region typically includes a base salary, performance bonuses tied to revenue and export growth, and dividends from equity holdings. Interviews Mukaetov has given to regional outlets, including Profit magazine and Nira Press, consistently describe a strategy of reinvestment and geographic expansion, which is consistent with a wealth profile built gradually through retained equity value rather than through asset sales or financial engineering.

There are also secondary indicators worth noting. The Trajce Mukaetov Foundation, a philanthropic vehicle associated with the family, made a €170,000 donation reported by AmCham North Macedonia in 2019. Named foundations of that type are typically established by high-net-worth families with the capacity for institutionalized giving, and they provide indirect evidence of significant accumulated wealth even without disclosing its total scale.

Assets and indicators: what is confirmed versus inferred

The honest assessment here is that the bulk of documented wealth evidence points to Alkaloid as the single primary asset. This is not unusual for founders or long-tenured executives of family-linked enterprises in the Balkans, where wealth concentration in a flagship company is a common pattern. Until a liquidity event, independent audit, or public disclosure surfaces, the real estate and investment picture remains largely inferred rather than confirmed.

Career timeline and the financial milestones that matter

1. Early 2000s: Mukaetov appears in Alkaloid management contexts in the 2003 and 2004 annual reports, establishing him as a senior figure well before his formal board appointment.
2. 2004: Officially becomes a member of Alkaloid's Board of Directors, a documented milestone marking the transition from executive management to governance.
3. 2006: Referenced as Chief Executive Officer in Alkaloid's Annual Report 2006, confirming his operational leadership at the company.
4. 2007: Appointed President of the Board of Directors, giving him the highest formal authority within the company's governance structure.
5. 2018 onward: Consistently identified in regional business media and investment promotion materials (including TIDZ events) as both General Director and Chairman, indicating sustained dual executive and governance control.
6. 2021–2022: Nira Press and other regional outlets quote him discussing continued investment and expansion, consistent with Alkaloid growing its employee base and geographic footprint during this period.
7. 2023: Al Jazeera Balkans features him in a profile noting over 2,000 employees including 600 outside North Macedonia, signaling meaningful international scale.
8. December 2024: First prominent public net worth estimate of €784 million published, placing him at the top of North Macedonia's wealth rankings.

The financial significance of this timeline is that Mukaetov has been accumulating equity value in Alkaloid for more than two decades without a documented exit. Each year of profitable operations translates into retained earnings and increased company valuation attributed to his stake. That is the compounding dynamic behind the headline number, not a single windfall transaction.

How to verify or refresh the net worth figure yourself

Because no single authoritative source publishes a real-time balance sheet for Mukaetov, verifying or updating the estimate requires checking a combination of sources. If you are specifically looking up Zoran Bogdanovic net worth, you will usually find similarly sourced estimates and ranges based on public records and related reporting rather than a disclosed balance sheet Mukaetov. Here is a practical approach:

1. Check Alkaloid's official website (alkaloid.com.mk) for the latest annual report. Revenue figures, profitability data, and any disclosed ownership changes will give you the most direct signal for reassessing company valuation.
2. Search for the most recent regional rich list that references Mukaetov. Oslobođenje, Forbes Adria, and Macedonian business outlets like eKapija and denar.mk periodically publish or update regional wealth rankings. Compare the publication date of any figure you find to confirm it is not recycling older estimates.
3. Cross-reference across at least two independent regional outlets. If multiple credible outlets report the same figure with similar sourcing, the estimate is more reliable than one that appears only in a single article.
4. Review Alkaloid's corporate news and press releases for any merger, acquisition, or capital market activity. A transaction would generate independent third-party valuations, which are the most reliable anchors for owner net worth estimates.
5. Check the North Macedonia Central Registry (Centralen Registar) at crm.com.mk for Alkaloid's filed financial statements, which are publicly accessible and reflect reported revenues, assets, and liabilities.
6. Note the currency and conversion rate used in any estimate. The €784 million figure is expressed in euros; if a source quotes a denar-denominated figure, divide by approximately 61.5 MKD per EUR (check the current rate as it fluctuates).
7. Treat any figure older than 12 to 18 months with skepticism and look for a more recent update, particularly if Alkaloid has announced major expansion, acquisition, or restructuring news in the interim.

For comparison context, it is worth knowing that other prominent Balkan executives and political figures from the same regional space, such as those covered on this site including figures from Slovenia, Croatia, Serbia, and North Macedonia, are estimated through similar methodologies. For comparison context, you can also look at zoran milanović net worth coverage on this site, where other prominent figures are estimated using broadly similar methodologies. The transparency of any estimate is directly tied to how much of the subject's income and assets flows through publicly reported channels. Mukaetov's wealth is concentrated in a single large company, which makes it easier to model but also more sensitive to valuation assumptions about that one asset.

The bottom line: €784 million is the best publicly available estimate as of late 2024, it is grounded in regional reporting with multiple outlets citing the same figure, and it is directionally consistent with the scale and profitability profile of Alkaloid. Treat it as an informed approximation within a range of roughly €600 million to €900 million, and revisit it whenever Alkaloid publishes a new annual report or a fresh regional wealth ranking appears. If you are also comparing other regional business profiles, you can use this zoran tosic net worth guide for a similar net worth research approach. If you are looking for the latest figures, a dedicated Zoran Janković net worth article can help you compare what different outlets report. If you are trying to verify the figure behind Zoran Kole net worth, the same approach applies: look for the originating rich list and then check what valuation inputs were used.